Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms
NCT ID: NCT07265817
Last Updated: 2025-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2025-12-01
2027-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Fecal Microbiota Transplantation on the Decolonization of Multidrug-resistant Organisms
NCT04583098
Efficacy and Safety of FMT for the Decolonization of MDROs in the Intestinal Tract
NCT06001333
Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization
NCT07106580
Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae
NCT05981430
FMT for Multidrug Resistant Organism Reversal
NCT02312986
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fecal microbiota transplantation group
Fecal Microbial transplant Capsules
3 pills per day for 3 consecutive days with placebo comparatator
Placebo
Placebo
The same amount and shape capsules
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fecal Microbial transplant Capsules
3 pills per day for 3 consecutive days with placebo comparatator
Placebo
The same amount and shape capsules
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyungpook National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eun Soo Kim, MD, PhD
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KNUH 2023-07-013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.